Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.23ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
JN.1.23SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-495.687Japan
JN.1.23SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-2556.23Japan
JN.1.23SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-5266.28Japan
KP.4.2.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
KP.4.2.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
KP.4.2.2ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
KP.4.2.2ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
KP.4.2.2ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
KP.4.2.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
KP.4.2.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
KP.4.2.2ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
KP.4.2.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
KP.4.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KP.4.2.2SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
KP.4.2.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
KP.4.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.4.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.4.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.4.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4.2.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
KP.4.2.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
KP.4.2.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
KP.4.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-20389.3US
KP.4.2.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
KP.4.2.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
KP.4.2.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
KP.4.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KP.4.2.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KP.4.2.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-16323.9Hong Kong
KP.4.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2.2ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-2242.74Japan
KP.4.2.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-1981.59Japan
KP.4.2.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-2648.21Japan
KP.4.2.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-22762.7Japan
KP.4.2.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-16362.7Japan
KP.4.2.2SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-16797.4Japan
LK.1ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
LK.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
LK.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
LK.1ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-1313China
LK.1ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
LK.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
LK.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
LK.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
LK.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
LK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LK.1SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
LK.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used